brimonidine tartrate has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, AM; Chung, HS; Fessler, HE; Otterbein, L | 1 |
| Bogers, JJ; De Man, JG; De Winter, BY; Herman, AG; Moreels, TG; Pelckmans, PA; Van Marck, EA | 1 |
| Abraham, E; Arcaroli, J; Kupfner, J; Park, JS; Pitts, TM; Strassheim, D; Yang, KY; Yum, HK | 1 |
3 other study(ies) available for brimonidine tartrate and mocetinostat
| Article | Year |
|---|---|
Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Creatinine; Escherichia coli; Hemodynamics; Lipopolysaccharides; Lung; Male; Peroxidase; Quinoxalines; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Necrosis Factor-alpha; Xylazine; Yohimbine | 1996 |
Disturbance of the prejunctional modulation of cholinergic neurotransmission during chronic granulomatous inflammation of the mouse ileum.
Topics: Adrenergic Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Antagonists; Animals; Brimonidine Tartrate; Carbachol; Cholinergic Agents; Cholinergic Agonists; Cholinergic Antagonists; Chronic Disease; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Electric Stimulation; Granuloma; Hexamethonium; Histamine; Histamine Agonists; Histamine Antagonists; Ileum; In Vitro Techniques; Male; Mice; Muscle Contraction; Neuromuscular Junction; Peroxidase; Quinoxalines; Receptors, Histamine; Schistosoma mansoni; Schistosomiasis mansoni; Synaptic Transmission; Tetrodotoxin | 2001 |
Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Brimonidine Tartrate; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Endotoxemia; Enzyme Activation; Hemorrhage; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neuroimmunomodulation; Neutrophils; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peroxidase; Phentolamine; Phenylephrine; Phosphorylation; Propranolol; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Quinoxalines; Respiratory Distress Syndrome; Ribosomal Protein S6 Kinases | 2002 |